Morphosys AG Common Stock

Morphosys AG (MOR) currently reports a common stock of $38M as of March 2024. That compares with $34M in the prior-year period — up 10.2% year over year. Use the charts on this page to explore Morphosys AG's common stock history and peer comparisons.

Morphosys AG's common stock increased from $34M to $38M — a 10.2% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Morphosys AG reported $38M in common stock as of March 2024. That compares with $34M in the prior-year period — up 10.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $38M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Morphosys AG, and consider following MOR for alerts when major investors trade the stock.

Morphosys AG is classified in the Healthcare sector. On common stock, it currently shows $38M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MOR with unrelated industries.